Akebia Therapeutics (AKBA), Vifor Pharma Enter Exclusive License Agreement to Provide Vadadustat to Fresenius Medical Care; Deal Includes $50M Equity Investment
Tweet Send to a Friend
Akebia Therapeutics, Inc. (NASDAQ: AKBA) and Vifor Pharma Group. today announced they have entered into an exclusive license agreement to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
